Evaluating the Risk-Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review
Background: The 2019 coronavirus (COVID-19) outbreak was declared a global pandemic in March 2020. It quickly spread across all continents, causing significant social, environmental, health, and economic impacts. During the pandemic, there has been consideration of repurposing and repositioning of m...
Saved in:
Main Authors: | Daniel Hsiang-Te Tsai (Author), Emma Harmon (Author), Jan Goelen (Author), Heather E. Barry (Author), Li-Yang Chen (Author), Yingfen Hsia (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
by: Takashi Inoue, et al.
Published: (2020) -
CLINICAL PROFILES OF VITILIGO WITH NARROWBAND UVB AND TOPICAL CORTICOSTEROID THERAPY AT DR. SOETOMO HOSPITAL
by: Sarah Fauzia, et al.
Published: (2020) -
Safety of corticosteroid therapy in sarcoidosis treatment
by: Alessandro Di Marco Berardino, et al.
Published: (2023) -
Topical therapy of infected corticosteroid-sensitive dermatoses
by: I. E. Torshina
Published: (2017) -
Systemic Corticosteroid Therapy And The Hypothalamopituitary-Adrenal Axis
by: Ramam M, et al.
Published: (2001)